Month: September 2024

Nominations open for the 2025 ASCI / Stanley J. Korsmeyer Award

Posted on by John Hawley

Nominations for the ASCI’s 2025 ASCI / Stanley J. Korsmeyer Award are now open.

This prestigious recognition, first called the ASCI Award, was renamed in 2006 in honor of Dr. Korsmeyer, the first recipient of the Award in 1998, who passed away in 2005. The Award recognizes individuals for their advancement of knowledge in a specific field and for mentoring future generations of life science researchers. Information on all past honorees is available here.

The Awardee delivers the Korsmeyer Award Lecture at the 2025 AAP/ASCI/APSA Joint Meeting and receives an unrestricted $20,000 honorarium.

Current Active and International ASCI members are eligible for nomination. Prior nominees who remain eligible may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

The deadline for receipt of nominations is October 23, 2024, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations, with the outcome of review expected toward the end of November 2023.

Nominators:

  • may be any ASCI member in good standing, including members of the Council;
  • must provide a statement (250-word limit) regarding the nominee; and
  • must comment regarding other investigators who have significantly contributed to the discoveries related to the nomination.

Nominees:

  • must currently be an Active or International member (age 55 or younger);
  • must provide a biosketch, full curriculum vitae, and a trainee table;
  • must identify a former mentee to provide a statement of support;
  • must complete the ASCI’s demographic survey; and
  • must identify their research domain(s).

To start a nomination:

Nominations may be started by the nominator or the nominee:

  • Access your member account
  • Go to the “Activities / nominations” tab
  • Go to the section for “ASCI / Stanley J. Korsmeyer Award”

For the nominator:

  • Select “I’m the nominator” option
  • Search for your nominee
  • Click on “Start nomination”
  • If the nominee has not already claimed her/his part of the nomination, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).
  • Supply the required information (see above)
  • Submit this aspect of the nomination

For the nominee:

  • Select “I’m the nominee” option
  • Supply the required information (see above)
  • Submit this aspect of the nomination

Nominations open for the 2025 ASCI / Scharschmidt~Crawford Distinguished Lectureship and Award

Posted on by John Hawley

Nominations for the ASCI’s 2025 Bruce F. Scharschmidt & Peggy S. Crawford Translational Medicine Distinguished Lectureship and Award are now open.

The Award recognizes those who have made important contributions to the development of high-impact diagnostics or therapeutics for patients. The Awardee delivers the Scharschmidt~Crawford Distinguished Lectureship at the annual AAP/ASCI/APSA Joint Meeting and receives an unrestricted $20,000 honorarium. Drs. Scharschmidt and Crawford have pledged a very generous philanthropic gift to the ASCI to fully endow the Award, the first of which will be presented at the 2025 Joint Meeting, April 25-27.

Any person with an MD or equivalent, regardless of ASCI membership, is eligible for nomination. However, current ASCI Council members may not be nominated.

The deadline for receipt of nominations is October 23, 2024, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations, with the outcome of review expected in December 2024.

Nominators:

  • may be any ASCI member in good standing, including members of the Council, and
  • must provide a statement (250-word limit) regarding the nominee.

Nominees:

  • may be any person with an MD or equivalent, regardless of ASCI membership, but excluding members of the Council;
  • must be able to attend the 2025 Joint Meeting, April 25-27, in Chicago;
  • must provide a 500-word-limit description of their contributions to the development of high-impact diagnostics or therapeutics for patients;
  • must provide a full curriculum vitae;
  • must complete the ASCI’s demographic survey; and
  • must provide information regarding their research domain(s).

To start a nomination:

Nominations may be started by the nominator or the nominee:

  • Access your member account
  • Go to the “Activities / nominations” tab
  • Go to the section for “ASCI / Scharschmidt~Crawford Distinguished Lectureship and Award”

For the nominator:

  • Select “I’m the nominator” option
  • Search for your nominee
  • Click on “Start nomination”
  • If the nominee has not already claimed her/his part of the nomination, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).
  • Supply the required information (see above)
  • Submit this aspect of the nomination

For the nominee:

  • Select “I’m the nominee” option
  • Supply the required information (see above)
  • Submit this aspect of the nomination

Nominations open for ASCI’s 2025 Early-Career Awards (E-Gen & YPSA)

Posted on by Colleen McGarry

Nominations for the ASCI’s 2025 Early-Career Awards – the Emerging-Generation Awards (E-Gen) and the Young Physician-Scientist Awards (YPSA) – are open through October 23, 2024 .

With these awards, the ASCI seeks to recognize early-career physician-scientists who have made notable achievements in their research, and to encourage and inspire them through their participation in the ASCI physician-scientist community.

Early-Career Award benefits include:

  • an honorarium
  • registration to the AAP/ASCI/APSA Joint Meeting during the award period
  • 2 years of longitudinal early-career specific programming including Leadership Development Workshops, networking opportunities and topical panels with ASCI members

Click here to view a webinar about these nomination processes. ASCI staff will be available via Zoom (link here) to answer your questions about the nomination process from 1 – 2 pm Eastern on the following dates:

  • September 6 (Friday), 18 (Wednesday)
  • October 1 (Tuesday), 14 (Monday)

Nominee eligibility criteria:

E-Gen: YPSA:

– has an MD, MD/PhD, or equivalent degree

– will have demonstrated creative promise during research training exemplified by publication and preprint activity (noted in biosketch)

– is currently meaningfully engaged in immersive research

– does not have an independent NIH K-08 level / equivalent award; a favorable score at the time of nomination is allowed

– must be nominated by an ASCI member

– may name a supporting contact, this person may provide a 250-word a letter of support

– has an MD, MD/PhD, or equivalent degree

– should preferably have a first faculty / institutional appointment within the past 5 years; if not within this range, nominees should note that extenuating circumstance(s) apply and may provide detail if they wish

– have a current NIH / comparable, foundation, or society-sponsored career development award (see nomination form for details)

– does not yet have current NIH R01 / equivalent independent project funding; a favorable score at the time of nomination is allowed. DP5s and R56s are also allowed; direct questions about R01 equivalents to programs@the-asci.org

– must be nominated by an ASCI member

– may name a supporting contact, this person may provide a 250-word a letter of support

The nominator must be an ASCI member in good standing and must start the nomination:

  • Access your member account
  • Go to the “Activities / nominations” tab, then click to the applicable nomination section
  • Select “I’m the nominator” option
  • Search for your nominee:
    • If found, click on “Start nomination”
    • If no result is found, provide and save the requested information (first name, last name, and email address), then click on “Create nomination” for the newly created nominee in the “Results” section.
  • At the top of the nomination form, click on “Send access notification to the nominee at: <email>”.
  • Provide a 250-word-limit statement regarding the nominee.
  • Submit the statement, which can be done regardless of whether the nominee’s part of the nomination is completed.

The nominee receives an email with information to access their part of the nomination and then must provide the following:

E-Gen YPSA

– nominee contact, education, funding information, and a headshot (the headshot will be used if awarded and is not used during the review process)

– a short bio (for use during review, and for public display if awarded)

– a brief NIH biosketch (as a PDF), using Section A. as a Scientific Vision Statement, rather than a Personal Statement, and including any funding information, for this award

– a completed ASCI demographics profile

– a completed ASCI research domains survey

– a supporter (optional), who may provide a statement of up to 250 words

– nominee contact, education, funding information, and a headshot (the headshot will be used if awarded and is not used during the review process

– a short bio (for use during review, and for public display if awarded)

– a brief NIH biosketch, including detailed funding information (as a PDF)

– a completed ASCI demographics profile

– a completed ASCI research domains survey

– a supporter (optional), who may provide a statement of up to 250 words

Note that the nominee can submit this information regardless of whether the nominator’s part of the nomination is completed.

Contact programs@the-asci.org with any questions.

Announcing the 2024-2025 ASCI Scientific Sessions, first up: Rohit Loomba, MD, MHSc – September 17, 2024, 1-2pm E

Posted on by Colleen McGarry

Photo of Dr. Rohit Loomba
Rohit Loomba, MD, MHSc

September 17, 1-2 pm Eastern

Rohit Loomba, MD, MHSc, Professor of Medicine and Chief, Division of Gastroenterology and Hepatology at the University of California, San Diego, and thought leader in translational research and innovative clinical trial design, will present:

Advances in Non-Invasive Assessment and Management of MASLD

Register here

This session will be moderated by Christopher Williams, MD, PhD, Professor of Medicine, Associate Dean of Physician Scientist Education and Training, and MSTP Director at Vanderbilt University School of Medicine. Dr. Williams is co-founder of the ASCI Physician-Scientist Development Committee.

Stay tuned for the following upcoming Scientific Sessions (all 1-2 pm Eastern):

Click here for more information and to view past ASCI Scientific Sessions.